Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

Denifanstat achieved statistically significant results on primary and multiple secondary endpoints in…

First Myeloma Patient Treated with CAR-T Successfully Discharged

SHANGHAI, Jan. 23, 2024 /PRNewswire/ — In another milestone since the implementation…

European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A)

YONGIN, South Korea, Jan. 23, 2024 /PRNewswire/ — GC Biopharma Corp. (006280.KS)…

More enterprises secure early spots at CIIE 2024

SHANGHAI, Jan. 23, 2024 /PRNewswire/ — Twenty-three companies had signed up early…

Musim Mas commits to achieving net-zero emissions by 2050, aligning with climate science as per the Science Based Targets Initiative (SBTi)

SINGAPORE, Jan. 23, 2024 /PRNewswire/ — Musim Mas’ commitment resonates with the…

36,000 units of MAIDeSITe Electric Floor Lift have been sold on Amazon

HANGZHOU, China, Jan. 23, 2024 /PRNewswire/ — The MAIDeSITe Electric Floor Lift is…

LPS Unveils New Brand Identity, Fully Embracing Lenovo's AI for All Transformation Journey in Asia Pacific

Rebranding supports Lenovo’s vision – ‘AI for ALL’ – by collaboratively enhancing…